Showing results (2211-2220 of 5,275) with videos related to

Sort By:
Pageof 528
Oncology|January 19, 2013
[(99m)Tc(CO)(3)]-radiolabeled bevacizumab: in vitro and in vivo evaluation in a melanoma modelXimena Camacho, María Fernanda García, Victoria Calzada, et al.
Oncology|May 22, 2013
In patients with colorectal cancer, preoperative serum interleukin-6 level and granulocyte/lymphocyte ratio are clinically relevant biomarkers of long-term cancer progressionJiro Shimazaki, Yoshihisa Goto, Kiyotaka Nishida, et al.
Oncology|January 1, 1990
Clinical staging of adult non-Hodgkin's lymphomaN Lalitha
Oncology|April 26, 2013
Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90Wan-Yee Lau, Bruno Sangro, Pier-Jer Chen, et al.
Oncology|April 19, 2013
S-1 monotherapy as second- or third-line chemotherapy for unresectable and recurrent esophageal squamous cell carcinomaYasunori Akutsu, Tsuguaki Kono, Masaya Uesato, et al.
Oncology|March 1, 2013
Phase II study of cetuximab in combination with docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck after platinum-containing therapy: a multicenter study of the Arbeitsgemeinschaft Internistische OnkologieM Knoedler, T C Gauler, V Gruenwald, et al.
Oncology|January 1, 1990
Detection of DNA strand breaks in HeLa cells in vitro and in mouse sarcoma 180 cells in vivo induced by an alkylating agent, carboquone, using in situ nick translationY Maehara, H Anai, Y Sakaguchi, et al.
Oncology|February 23, 2013
Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: recent progression and perspectiveKenichi Takayasu
Oncology|February 23, 2013
Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CTTatsuo Inoue, Masatoshi Kudo, Kinuyo Hatanaka, et al.
Oncology|February 1, 2013
Effect of the BCL2 gene polymorphism on survival in advanced-stage non-small cell lung cancer patients who received chemotherapyKatsuhiro Masago, Yosuke Togashi, Shiro Fujita, et al.
Pageof 528